nodes	percent_of_prediction	percent_of_DWPC	metapath
Mifepristone—NR3C1—systemic lupus erythematosus	0.289	1	CbGaD
Mifepristone—PGR—Betamethasone—systemic lupus erythematosus	0.0556	0.0949	CbGbCtD
Mifepristone—NR3C1—Methylprednisolone—systemic lupus erythematosus	0.0437	0.0745	CbGbCtD
Mifepristone—NR3C1—Triamcinolone—systemic lupus erythematosus	0.0331	0.0565	CbGbCtD
Mifepristone—PGR—Dexamethasone—systemic lupus erythematosus	0.0323	0.0552	CbGbCtD
Mifepristone—NR3C1—Betamethasone—systemic lupus erythematosus	0.0284	0.0484	CbGbCtD
Mifepristone—NR3C1—Prednisolone—systemic lupus erythematosus	0.028	0.0478	CbGbCtD
Mifepristone—NR3C1—Hydrocortisone—systemic lupus erythematosus	0.0265	0.0453	CbGbCtD
Mifepristone—NR3C1—Prednisone—systemic lupus erythematosus	0.0264	0.0451	CbGbCtD
Mifepristone—ABCC1—Cyclosporine—systemic lupus erythematosus	0.0242	0.0413	CbGbCtD
Mifepristone—CYP3A7-CYP3A51P—Dapsone—systemic lupus erythematosus	0.0182	0.0311	CbGbCtD
Mifepristone—CYP3A7—Dapsone—systemic lupus erythematosus	0.0182	0.0311	CbGbCtD
Mifepristone—NR3C1—Dexamethasone—systemic lupus erythematosus	0.0165	0.0282	CbGbCtD
Mifepristone—CYP3A5—Dapsone—systemic lupus erythematosus	0.0137	0.0233	CbGbCtD
Mifepristone—ABCC1—Methotrexate—systemic lupus erythematosus	0.0128	0.0219	CbGbCtD
Mifepristone—CYP3A7-CYP3A51P—Hydrocortisone—systemic lupus erythematosus	0.0127	0.0216	CbGbCtD
Mifepristone—CYP3A7—Hydrocortisone—systemic lupus erythematosus	0.0127	0.0216	CbGbCtD
Mifepristone—CYP3A7-CYP3A51P—Cyclosporine—systemic lupus erythematosus	0.012	0.0204	CbGbCtD
Mifepristone—CYP3A7—Cyclosporine—systemic lupus erythematosus	0.012	0.0204	CbGbCtD
Mifepristone—CYP3A5—Mycophenolate mofetil—systemic lupus erythematosus	0.0118	0.0202	CbGbCtD
Mifepristone—ABCB1—Methylprednisolone—systemic lupus erythematosus	0.0102	0.0174	CbGbCtD
Mifepristone—CYP3A5—Hydrocortisone—systemic lupus erythematosus	0.0095	0.0162	CbGbCtD
Mifepristone—CYP3A5—Cyclosporine—systemic lupus erythematosus	0.00897	0.0153	CbGbCtD
Mifepristone—CYP3A7-CYP3A51P—Dexamethasone—systemic lupus erythematosus	0.00787	0.0134	CbGbCtD
Mifepristone—CYP3A7—Dexamethasone—systemic lupus erythematosus	0.00787	0.0134	CbGbCtD
Mifepristone—ABCB1—Mycophenolate mofetil—systemic lupus erythematosus	0.0077	0.0132	CbGbCtD
Mifepristone—ABCB1—Betamethasone—systemic lupus erythematosus	0.00661	0.0113	CbGbCtD
Mifepristone—ABCB1—Prednisolone—systemic lupus erythematosus	0.00652	0.0111	CbGbCtD
Mifepristone—ABCB1—Hydrocortisone—systemic lupus erythematosus	0.00618	0.0106	CbGbCtD
Mifepristone—ABCB1—Prednisone—systemic lupus erythematosus	0.00616	0.0105	CbGbCtD
Mifepristone—CYP3A4—Methylprednisolone—systemic lupus erythematosus	0.00609	0.0104	CbGbCtD
Mifepristone—CYP3A5—Dexamethasone—systemic lupus erythematosus	0.00591	0.0101	CbGbCtD
Mifepristone—ABCB1—Cyclosporine—systemic lupus erythematosus	0.00584	0.00997	CbGbCtD
Mifepristone—CYP2D6—Cyclosporine—systemic lupus erythematosus	0.0055	0.00939	CbGbCtD
Mifepristone—CYP3A4—Dapsone—systemic lupus erythematosus	0.00532	0.00909	CbGbCtD
Mifepristone—CYP3A4—Mycophenolate mofetil—systemic lupus erythematosus	0.00462	0.00788	CbGbCtD
Mifepristone—CYP3A4—Triamcinolone—systemic lupus erythematosus	0.00462	0.00788	CbGbCtD
Mifepristone—CYP3A4—Betamethasone—systemic lupus erythematosus	0.00396	0.00676	CbGbCtD
Mifepristone—CYP3A4—Prednisolone—systemic lupus erythematosus	0.00391	0.00667	CbGbCtD
Mifepristone—ABCB1—Dexamethasone—systemic lupus erythematosus	0.00384	0.00656	CbGbCtD
Mifepristone—CYP3A4—Hydrocortisone—systemic lupus erythematosus	0.0037	0.00632	CbGbCtD
Mifepristone—CYP3A4—Prednisone—systemic lupus erythematosus	0.00369	0.0063	CbGbCtD
Mifepristone—CYP2D6—Dexamethasone—systemic lupus erythematosus	0.00362	0.00618	CbGbCtD
Mifepristone—CYP3A4—Cyclosporine—systemic lupus erythematosus	0.0035	0.00597	CbGbCtD
Mifepristone—ABCB1—Methotrexate—systemic lupus erythematosus	0.00309	0.00527	CbGbCtD
Mifepristone—CYP3A4—Dexamethasone—systemic lupus erythematosus	0.0023	0.00393	CbGbCtD
Mifepristone—NR3C1—urine—systemic lupus erythematosus	0.00141	0.0636	CbGeAlD
Mifepristone—CYP3A4—urine—systemic lupus erythematosus	0.00107	0.0481	CbGeAlD
Mifepristone—CYP2D6—urine—systemic lupus erythematosus	0.00105	0.0474	CbGeAlD
Mifepristone—CYP3A7-CYP3A51P—nephron tubule—systemic lupus erythematosus	0.000923	0.0417	CbGeAlD
Mifepristone—CYP3A7-CYP3A51P—cortex of kidney—systemic lupus erythematosus	0.00079	0.0357	CbGeAlD
Mifepristone—CYP3A5—blood plasma—systemic lupus erythematosus	0.000741	0.0335	CbGeAlD
Mifepristone—NR3C1—blood plasma—systemic lupus erythematosus	0.000735	0.0332	CbGeAlD
Mifepristone—PGR—connective tissue—systemic lupus erythematosus	0.000678	0.0306	CbGeAlD
Mifepristone—CYP3A4—blood plasma—systemic lupus erythematosus	0.000556	0.0251	CbGeAlD
Mifepristone—CYP2D6—blood plasma—systemic lupus erythematosus	0.000547	0.0247	CbGeAlD
Mifepristone—AR—connective tissue—systemic lupus erythematosus	0.00054	0.0244	CbGeAlD
Mifepristone—PGR—lymphoid tissue—systemic lupus erythematosus	0.000496	0.0224	CbGeAlD
Mifepristone—AR—skin of body—systemic lupus erythematosus	0.000488	0.022	CbGeAlD
Mifepristone—AR—kidney—systemic lupus erythematosus	0.00046	0.0208	CbGeAlD
Mifepristone—AR—cortex of kidney—systemic lupus erythematosus	0.000448	0.0202	CbGeAlD
Mifepristone—ABCC1—cortex of kidney—systemic lupus erythematosus	0.000426	0.0192	CbGeAlD
Mifepristone—PGR—lung—systemic lupus erythematosus	0.000409	0.0185	CbGeAlD
Mifepristone—AR—lymphoid tissue—systemic lupus erythematosus	0.000395	0.0179	CbGeAlD
Mifepristone—ABCB1—blood plasma—systemic lupus erythematosus	0.000394	0.0178	CbGeAlD
Mifepristone—NR3C1—connective tissue—systemic lupus erythematosus	0.000391	0.0177	CbGeAlD
Mifepristone—CYP3A5—nephron tubule—systemic lupus erythematosus	0.000382	0.0173	CbGeAlD
Mifepristone—NR3C1—nephron tubule—systemic lupus erythematosus	0.000379	0.0171	CbGeAlD
Mifepristone—PGR—nervous system—systemic lupus erythematosus	0.000379	0.0171	CbGeAlD
Mifepristone—AR—tendon—systemic lupus erythematosus	0.000371	0.0168	CbGeAlD
Mifepristone—PGR—central nervous system—systemic lupus erythematosus	0.000365	0.0165	CbGeAlD
Mifepristone—NR3C1—skin of body—systemic lupus erythematosus	0.000353	0.016	CbGeAlD
Mifepristone—ABCC1—tendon—systemic lupus erythematosus	0.000353	0.0159	CbGeAlD
Mifepristone—CYP3A5—kidney—systemic lupus erythematosus	0.000336	0.0152	CbGeAlD
Mifepristone—NR3C1—kidney—systemic lupus erythematosus	0.000333	0.0151	CbGeAlD
Mifepristone—CYP3A5—cortex of kidney—systemic lupus erythematosus	0.000327	0.0148	CbGeAlD
Mifepristone—AR—lung—systemic lupus erythematosus	0.000326	0.0147	CbGeAlD
Mifepristone—NR3C1—cortex of kidney—systemic lupus erythematosus	0.000324	0.0147	CbGeAlD
Mifepristone—ABCC1—lung—systemic lupus erythematosus	0.00031	0.014	CbGeAlD
Mifepristone—AR—nervous system—systemic lupus erythematosus	0.000302	0.0136	CbGeAlD
Mifepristone—AR—central nervous system—systemic lupus erythematosus	0.000291	0.0131	CbGeAlD
Mifepristone—NR3C1—lymphoid tissue—systemic lupus erythematosus	0.000286	0.0129	CbGeAlD
Mifepristone—NR3C1—tendon—systemic lupus erythematosus	0.000269	0.0122	CbGeAlD
Mifepristone—NR3C1—bone marrow—systemic lupus erythematosus	0.000261	0.0118	CbGeAlD
Mifepristone—CYP3A4—kidney—systemic lupus erythematosus	0.000252	0.0114	CbGeAlD
Mifepristone—CYP2D6—kidney—systemic lupus erythematosus	0.000248	0.0112	CbGeAlD
Mifepristone—CYP3A5—lung—systemic lupus erythematosus	0.000238	0.0107	CbGeAlD
Mifepristone—NR3C1—lung—systemic lupus erythematosus	0.000236	0.0107	CbGeAlD
Mifepristone—NR3C1—nervous system—systemic lupus erythematosus	0.000219	0.00988	CbGeAlD
Mifepristone—NR3C1—central nervous system—systemic lupus erythematosus	0.00021	0.00951	CbGeAlD
Mifepristone—ABCB1—nephron tubule—systemic lupus erythematosus	0.000203	0.00917	CbGeAlD
Mifepristone—ABCB1—kidney—systemic lupus erythematosus	0.000178	0.00806	CbGeAlD
Mifepristone—ABCB1—cortex of kidney—systemic lupus erythematosus	0.000174	0.00785	CbGeAlD
Mifepristone—CYP3A4—nervous system—systemic lupus erythematosus	0.000165	0.00747	CbGeAlD
Mifepristone—CYP2D6—nervous system—systemic lupus erythematosus	0.000163	0.00735	CbGeAlD
Mifepristone—CYP3A4—central nervous system—systemic lupus erythematosus	0.000159	0.00719	CbGeAlD
Mifepristone—CYP2D6—central nervous system—systemic lupus erythematosus	0.000157	0.00708	CbGeAlD
Mifepristone—ABCB1—lymphoid tissue—systemic lupus erythematosus	0.000153	0.00692	CbGeAlD
Mifepristone—ABCB1—bone marrow—systemic lupus erythematosus	0.00014	0.0063	CbGeAlD
Mifepristone—ABCB1—lung—systemic lupus erythematosus	0.000126	0.00571	CbGeAlD
Mifepristone—Angiopathy—Prednisone—systemic lupus erythematosus	0.000123	0.00144	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000123	0.00143	CcSEcCtD
Mifepristone—Malaise—Betamethasone—systemic lupus erythematosus	0.000122	0.00143	CcSEcCtD
Mifepristone—Malaise—Dexamethasone—systemic lupus erythematosus	0.000122	0.00143	CcSEcCtD
Mifepristone—Oedema—Triamcinolone—systemic lupus erythematosus	0.000122	0.00142	CcSEcCtD
Mifepristone—Constipation—Mycophenolate mofetil—systemic lupus erythematosus	0.000121	0.00142	CcSEcCtD
Mifepristone—Pain—Mycophenolate mofetil—systemic lupus erythematosus	0.000121	0.00142	CcSEcCtD
Mifepristone—Infection—Triamcinolone—systemic lupus erythematosus	0.000121	0.00141	CcSEcCtD
Mifepristone—Hypotension—Hydrocortisone—systemic lupus erythematosus	0.000121	0.00141	CcSEcCtD
Mifepristone—Infection—Methylprednisolone—systemic lupus erythematosus	0.000121	0.00141	CcSEcCtD
Mifepristone—Feeling abnormal—Cyclosporine—systemic lupus erythematosus	0.00012	0.0014	CcSEcCtD
Mifepristone—Vomiting—Leflunomide—systemic lupus erythematosus	0.00012	0.0014	CcSEcCtD
Mifepristone—Insomnia—Prednisolone—systemic lupus erythematosus	0.00012	0.0014	CcSEcCtD
Mifepristone—Nervous system disorder—Methylprednisolone—systemic lupus erythematosus	0.000119	0.00139	CcSEcCtD
Mifepristone—Gastrointestinal pain—Cyclosporine—systemic lupus erythematosus	0.000119	0.00139	CcSEcCtD
Mifepristone—Rash—Leflunomide—systemic lupus erythematosus	0.000119	0.00139	CcSEcCtD
Mifepristone—Dermatitis—Leflunomide—systemic lupus erythematosus	0.000119	0.00139	CcSEcCtD
Mifepristone—Mental disorder—Prednisone—systemic lupus erythematosus	0.000119	0.00139	CcSEcCtD
Mifepristone—Nausea—Azathioprine—systemic lupus erythematosus	0.000119	0.00138	CcSEcCtD
Mifepristone—Headache—Leflunomide—systemic lupus erythematosus	0.000118	0.00138	CcSEcCtD
Mifepristone—Skin disorder—Methylprednisolone—systemic lupus erythematosus	0.000118	0.00138	CcSEcCtD
Mifepristone—Malnutrition—Prednisone—systemic lupus erythematosus	0.000118	0.00138	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Hydrocortisone—systemic lupus erythematosus	0.000118	0.00138	CcSEcCtD
Mifepristone—ABCB1—nervous system—systemic lupus erythematosus	0.000117	0.00529	CbGeAlD
Mifepristone—Feeling abnormal—Mycophenolate mofetil—systemic lupus erythematosus	0.000117	0.00137	CcSEcCtD
Mifepristone—Insomnia—Hydrocortisone—systemic lupus erythematosus	0.000117	0.00137	CcSEcCtD
Mifepristone—Hypertension—Dexamethasone—systemic lupus erythematosus	0.000117	0.00137	CcSEcCtD
Mifepristone—Hypertension—Betamethasone—systemic lupus erythematosus	0.000117	0.00137	CcSEcCtD
Mifepristone—Gastrointestinal pain—Mycophenolate mofetil—systemic lupus erythematosus	0.000116	0.00136	CcSEcCtD
Mifepristone—Urticaria—Cyclosporine—systemic lupus erythematosus	0.000116	0.00135	CcSEcCtD
Mifepristone—Myalgia—Dexamethasone—systemic lupus erythematosus	0.000115	0.00135	CcSEcCtD
Mifepristone—Myalgia—Betamethasone—systemic lupus erythematosus	0.000115	0.00135	CcSEcCtD
Mifepristone—Abdominal pain—Cyclosporine—systemic lupus erythematosus	0.000115	0.00134	CcSEcCtD
Mifepristone—Body temperature increased—Cyclosporine—systemic lupus erythematosus	0.000115	0.00134	CcSEcCtD
Mifepristone—Anxiety—Dexamethasone—systemic lupus erythematosus	0.000115	0.00134	CcSEcCtD
Mifepristone—Anxiety—Betamethasone—systemic lupus erythematosus	0.000115	0.00134	CcSEcCtD
Mifepristone—Discomfort—Dexamethasone—systemic lupus erythematosus	0.000114	0.00133	CcSEcCtD
Mifepristone—Discomfort—Betamethasone—systemic lupus erythematosus	0.000114	0.00133	CcSEcCtD
Mifepristone—Haemoglobin—Methotrexate—systemic lupus erythematosus	0.000114	0.00133	CcSEcCtD
Mifepristone—Hypotension—Methylprednisolone—systemic lupus erythematosus	0.000114	0.00133	CcSEcCtD
Mifepristone—Pain—Prednisolone—systemic lupus erythematosus	0.000113	0.00132	CcSEcCtD
Mifepristone—Haemorrhage—Methotrexate—systemic lupus erythematosus	0.000113	0.00132	CcSEcCtD
Mifepristone—Urticaria—Mycophenolate mofetil—systemic lupus erythematosus	0.000113	0.00132	CcSEcCtD
Mifepristone—ABCB1—central nervous system—systemic lupus erythematosus	0.000113	0.00509	CbGeAlD
Mifepristone—Decreased appetite—Hydrocortisone—systemic lupus erythematosus	0.000112	0.00131	CcSEcCtD
Mifepristone—Abdominal pain—Mycophenolate mofetil—systemic lupus erythematosus	0.000112	0.00131	CcSEcCtD
Mifepristone—Body temperature increased—Mycophenolate mofetil—systemic lupus erythematosus	0.000112	0.00131	CcSEcCtD
Mifepristone—Nausea—Leflunomide—systemic lupus erythematosus	0.000112	0.00131	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Hydrocortisone—systemic lupus erythematosus	0.000112	0.0013	CcSEcCtD
Mifepristone—Fatigue—Hydrocortisone—systemic lupus erythematosus	0.000111	0.0013	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Triamcinolone—systemic lupus erythematosus	0.000111	0.0013	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Methylprednisolone—systemic lupus erythematosus	0.000111	0.00129	CcSEcCtD
Mifepristone—Pain—Hydrocortisone—systemic lupus erythematosus	0.000111	0.00129	CcSEcCtD
Mifepristone—Oedema—Betamethasone—systemic lupus erythematosus	0.00011	0.00129	CcSEcCtD
Mifepristone—Oedema—Dexamethasone—systemic lupus erythematosus	0.00011	0.00129	CcSEcCtD
Mifepristone—Insomnia—Triamcinolone—systemic lupus erythematosus	0.00011	0.00129	CcSEcCtD
Mifepristone—Insomnia—Methylprednisolone—systemic lupus erythematosus	0.00011	0.00128	CcSEcCtD
Mifepristone—Infection—Betamethasone—systemic lupus erythematosus	0.00011	0.00128	CcSEcCtD
Mifepristone—Infection—Dexamethasone—systemic lupus erythematosus	0.00011	0.00128	CcSEcCtD
Mifepristone—Ill-defined disorder—Prednisone—systemic lupus erythematosus	0.000109	0.00128	CcSEcCtD
Mifepristone—Feeling abnormal—Prednisolone—systemic lupus erythematosus	0.000109	0.00127	CcSEcCtD
Mifepristone—Dyspnoea—Triamcinolone—systemic lupus erythematosus	0.000109	0.00127	CcSEcCtD
Mifepristone—Nervous system disorder—Betamethasone—systemic lupus erythematosus	0.000108	0.00127	CcSEcCtD
Mifepristone—Nervous system disorder—Dexamethasone—systemic lupus erythematosus	0.000108	0.00127	CcSEcCtD
Mifepristone—Angioedema—Prednisone—systemic lupus erythematosus	0.000108	0.00126	CcSEcCtD
Mifepristone—Hypersensitivity—Cyclosporine—systemic lupus erythematosus	0.000107	0.00125	CcSEcCtD
Mifepristone—Feeling abnormal—Hydrocortisone—systemic lupus erythematosus	0.000107	0.00124	CcSEcCtD
Mifepristone—Malaise—Prednisone—systemic lupus erythematosus	0.000106	0.00124	CcSEcCtD
Mifepristone—Gastrointestinal pain—Hydrocortisone—systemic lupus erythematosus	0.000106	0.00123	CcSEcCtD
Mifepristone—Anorexia—Dexamethasone—systemic lupus erythematosus	0.000105	0.00123	CcSEcCtD
Mifepristone—Anorexia—Betamethasone—systemic lupus erythematosus	0.000105	0.00123	CcSEcCtD
Mifepristone—Urticaria—Prednisolone—systemic lupus erythematosus	0.000105	0.00123	CcSEcCtD
Mifepristone—Fatigue—Triamcinolone—systemic lupus erythematosus	0.000105	0.00123	CcSEcCtD
Mifepristone—Fatigue—Methylprednisolone—systemic lupus erythematosus	0.000105	0.00122	CcSEcCtD
Mifepristone—Hypersensitivity—Mycophenolate mofetil—systemic lupus erythematosus	0.000105	0.00122	CcSEcCtD
Mifepristone—Asthenia—Cyclosporine—systemic lupus erythematosus	0.000104	0.00122	CcSEcCtD
Mifepristone—Pain—Triamcinolone—systemic lupus erythematosus	0.000104	0.00122	CcSEcCtD
Mifepristone—Hypotension—Betamethasone—systemic lupus erythematosus	0.000103	0.00121	CcSEcCtD
Mifepristone—Hypotension—Dexamethasone—systemic lupus erythematosus	0.000103	0.00121	CcSEcCtD
Mifepristone—Pruritus—Cyclosporine—systemic lupus erythematosus	0.000103	0.0012	CcSEcCtD
Mifepristone—Urticaria—Hydrocortisone—systemic lupus erythematosus	0.000103	0.0012	CcSEcCtD
Mifepristone—Angiopathy—Methotrexate—systemic lupus erythematosus	0.000103	0.0012	CcSEcCtD
Mifepristone—Abdominal pain—Hydrocortisone—systemic lupus erythematosus	0.000102	0.00119	CcSEcCtD
Mifepristone—Body temperature increased—Hydrocortisone—systemic lupus erythematosus	0.000102	0.00119	CcSEcCtD
Mifepristone—Mediastinal disorder—Methotrexate—systemic lupus erythematosus	0.000102	0.00119	CcSEcCtD
Mifepristone—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	0.000102	0.00119	CcSEcCtD
Mifepristone—Hypertension—Prednisone—systemic lupus erythematosus	0.000102	0.00119	CcSEcCtD
Mifepristone—Chills—Methotrexate—systemic lupus erythematosus	0.000102	0.00119	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Dexamethasone—systemic lupus erythematosus	0.000101	0.00118	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Betamethasone—systemic lupus erythematosus	0.000101	0.00118	CcSEcCtD
Mifepristone—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	0.0001	0.00117	CcSEcCtD
Mifepristone—Myalgia—Prednisone—systemic lupus erythematosus	0.0001	0.00117	CcSEcCtD
Mifepristone—Arthralgia—Prednisone—systemic lupus erythematosus	0.0001	0.00117	CcSEcCtD
Mifepristone—Feeling abnormal—Triamcinolone—systemic lupus erythematosus	0.0001	0.00117	CcSEcCtD
Mifepristone—Feeling abnormal—Methylprednisolone—systemic lupus erythematosus	0.0001	0.00117	CcSEcCtD
Mifepristone—Anxiety—Prednisone—systemic lupus erythematosus	0.0001	0.00117	CcSEcCtD
Mifepristone—Insomnia—Dexamethasone—systemic lupus erythematosus	9.99e-05	0.00117	CcSEcCtD
Mifepristone—Insomnia—Betamethasone—systemic lupus erythematosus	9.99e-05	0.00117	CcSEcCtD
Mifepristone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic lupus erythematosus	9.97e-05	0.00116	CcSEcCtD
Mifepristone—Diarrhoea—Cyclosporine—systemic lupus erythematosus	9.95e-05	0.00116	CcSEcCtD
Mifepristone—Gastrointestinal pain—Methylprednisolone—systemic lupus erythematosus	9.93e-05	0.00116	CcSEcCtD
Mifepristone—Discomfort—Prednisone—systemic lupus erythematosus	9.92e-05	0.00116	CcSEcCtD
Mifepristone—Mental disorder—Methotrexate—systemic lupus erythematosus	9.91e-05	0.00116	CcSEcCtD
Mifepristone—Malnutrition—Methotrexate—systemic lupus erythematosus	9.85e-05	0.00115	CcSEcCtD
Mifepristone—Hypersensitivity—Prednisolone—systemic lupus erythematosus	9.75e-05	0.00114	CcSEcCtD
Mifepristone—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	9.71e-05	0.00113	CcSEcCtD
Mifepristone—Urticaria—Triamcinolone—systemic lupus erythematosus	9.67e-05	0.00113	CcSEcCtD
Mifepristone—Urticaria—Methylprednisolone—systemic lupus erythematosus	9.65e-05	0.00113	CcSEcCtD
Mifepristone—Body temperature increased—Triamcinolone—systemic lupus erythematosus	9.62e-05	0.00112	CcSEcCtD
Mifepristone—Dizziness—Cyclosporine—systemic lupus erythematosus	9.62e-05	0.00112	CcSEcCtD
Mifepristone—Oedema—Prednisone—systemic lupus erythematosus	9.62e-05	0.00112	CcSEcCtD
Mifepristone—Abdominal pain—Methylprednisolone—systemic lupus erythematosus	9.6e-05	0.00112	CcSEcCtD
Mifepristone—Decreased appetite—Dexamethasone—systemic lupus erythematosus	9.6e-05	0.00112	CcSEcCtD
Mifepristone—Decreased appetite—Betamethasone—systemic lupus erythematosus	9.6e-05	0.00112	CcSEcCtD
Mifepristone—Infection—Prednisone—systemic lupus erythematosus	9.56e-05	0.00112	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	9.54e-05	0.00111	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	9.54e-05	0.00111	CcSEcCtD
Mifepristone—Back pain—Methotrexate—systemic lupus erythematosus	9.53e-05	0.00111	CcSEcCtD
Mifepristone—Hypersensitivity—Hydrocortisone—systemic lupus erythematosus	9.53e-05	0.00111	CcSEcCtD
Mifepristone—Fatigue—Dexamethasone—systemic lupus erythematosus	9.52e-05	0.00111	CcSEcCtD
Mifepristone—Fatigue—Betamethasone—systemic lupus erythematosus	9.52e-05	0.00111	CcSEcCtD
Mifepristone—Pain—Dexamethasone—systemic lupus erythematosus	9.45e-05	0.0011	CcSEcCtD
Mifepristone—Pain—Betamethasone—systemic lupus erythematosus	9.45e-05	0.0011	CcSEcCtD
Mifepristone—Nervous system disorder—Prednisone—systemic lupus erythematosus	9.43e-05	0.0011	CcSEcCtD
Mifepristone—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	9.39e-05	0.0011	CcSEcCtD
Mifepristone—Skin disorder—Prednisone—systemic lupus erythematosus	9.34e-05	0.00109	CcSEcCtD
Mifepristone—Asthenia—Hydrocortisone—systemic lupus erythematosus	9.28e-05	0.00108	CcSEcCtD
Mifepristone—Vomiting—Cyclosporine—systemic lupus erythematosus	9.25e-05	0.00108	CcSEcCtD
Mifepristone—Rash—Cyclosporine—systemic lupus erythematosus	9.17e-05	0.00107	CcSEcCtD
Mifepristone—Anorexia—Prednisone—systemic lupus erythematosus	9.17e-05	0.00107	CcSEcCtD
Mifepristone—Dermatitis—Cyclosporine—systemic lupus erythematosus	9.16e-05	0.00107	CcSEcCtD
Mifepristone—Pruritus—Hydrocortisone—systemic lupus erythematosus	9.15e-05	0.00107	CcSEcCtD
Mifepristone—Ill-defined disorder—Methotrexate—systemic lupus erythematosus	9.14e-05	0.00107	CcSEcCtD
Mifepristone—Headache—Cyclosporine—systemic lupus erythematosus	9.11e-05	0.00106	CcSEcCtD
Mifepristone—Feeling abnormal—Dexamethasone—systemic lupus erythematosus	9.1e-05	0.00106	CcSEcCtD
Mifepristone—Feeling abnormal—Betamethasone—systemic lupus erythematosus	9.1e-05	0.00106	CcSEcCtD
Mifepristone—Gastrointestinal pain—Betamethasone—systemic lupus erythematosus	9.03e-05	0.00106	CcSEcCtD
Mifepristone—Gastrointestinal pain—Dexamethasone—systemic lupus erythematosus	9.03e-05	0.00106	CcSEcCtD
Mifepristone—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	9.02e-05	0.00105	CcSEcCtD
Mifepristone—Hypersensitivity—Triamcinolone—systemic lupus erythematosus	8.97e-05	0.00105	CcSEcCtD
Mifepristone—Hypersensitivity—Methylprednisolone—systemic lupus erythematosus	8.95e-05	0.00105	CcSEcCtD
Mifepristone—Rash—Mycophenolate mofetil—systemic lupus erythematosus	8.95e-05	0.00105	CcSEcCtD
Mifepristone—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	8.94e-05	0.00104	CcSEcCtD
Mifepristone—Headache—Mycophenolate mofetil—systemic lupus erythematosus	8.89e-05	0.00104	CcSEcCtD
Mifepristone—Malaise—Methotrexate—systemic lupus erythematosus	8.88e-05	0.00104	CcSEcCtD
Mifepristone—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	8.85e-05	0.00103	CcSEcCtD
Mifepristone—Urticaria—Dexamethasone—systemic lupus erythematosus	8.78e-05	0.00103	CcSEcCtD
Mifepristone—Urticaria—Betamethasone—systemic lupus erythematosus	8.78e-05	0.00103	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Prednisone—systemic lupus erythematosus	8.76e-05	0.00102	CcSEcCtD
Mifepristone—Dizziness—Prednisolone—systemic lupus erythematosus	8.75e-05	0.00102	CcSEcCtD
Mifepristone—Asthenia—Triamcinolone—systemic lupus erythematosus	8.74e-05	0.00102	CcSEcCtD
Mifepristone—Abdominal pain—Dexamethasone—systemic lupus erythematosus	8.73e-05	0.00102	CcSEcCtD
Mifepristone—Abdominal pain—Betamethasone—systemic lupus erythematosus	8.73e-05	0.00102	CcSEcCtD
Mifepristone—Body temperature increased—Dexamethasone—systemic lupus erythematosus	8.73e-05	0.00102	CcSEcCtD
Mifepristone—Body temperature increased—Betamethasone—systemic lupus erythematosus	8.73e-05	0.00102	CcSEcCtD
Mifepristone—Asthenia—Methylprednisolone—systemic lupus erythematosus	8.72e-05	0.00102	CcSEcCtD
Mifepristone—Insomnia—Prednisone—systemic lupus erythematosus	8.7e-05	0.00102	CcSEcCtD
Mifepristone—Nausea—Cyclosporine—systemic lupus erythematosus	8.64e-05	0.00101	CcSEcCtD
Mifepristone—Pruritus—Triamcinolone—systemic lupus erythematosus	8.61e-05	0.00101	CcSEcCtD
Mifepristone—Pruritus—Methylprednisolone—systemic lupus erythematosus	8.59e-05	0.001	CcSEcCtD
Mifepristone—Dizziness—Hydrocortisone—systemic lupus erythematosus	8.55e-05	0.000999	CcSEcCtD
Mifepristone—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	8.43e-05	0.000985	CcSEcCtD
Mifepristone—Myalgia—Methotrexate—systemic lupus erythematosus	8.39e-05	0.00098	CcSEcCtD
Mifepristone—Arthralgia—Methotrexate—systemic lupus erythematosus	8.39e-05	0.00098	CcSEcCtD
Mifepristone—Decreased appetite—Prednisone—systemic lupus erythematosus	8.36e-05	0.000977	CcSEcCtD
Mifepristone—Rash—Prednisolone—systemic lupus erythematosus	8.35e-05	0.000975	CcSEcCtD
Mifepristone—Dermatitis—Prednisolone—systemic lupus erythematosus	8.34e-05	0.000974	CcSEcCtD
Mifepristone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic lupus erythematosus	8.33e-05	0.000973	CcSEcCtD
Mifepristone—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	8.31e-05	0.000971	CcSEcCtD
Mifepristone—Fatigue—Prednisone—systemic lupus erythematosus	8.29e-05	0.000969	CcSEcCtD
Mifepristone—Headache—Prednisolone—systemic lupus erythematosus	8.29e-05	0.000969	CcSEcCtD
Mifepristone—Discomfort—Methotrexate—systemic lupus erythematosus	8.29e-05	0.000968	CcSEcCtD
Mifepristone—Constipation—Prednisone—systemic lupus erythematosus	8.23e-05	0.000961	CcSEcCtD
Mifepristone—Vomiting—Hydrocortisone—systemic lupus erythematosus	8.22e-05	0.00096	CcSEcCtD
Mifepristone—Rash—Hydrocortisone—systemic lupus erythematosus	8.15e-05	0.000952	CcSEcCtD
Mifepristone—Dermatitis—Hydrocortisone—systemic lupus erythematosus	8.14e-05	0.000951	CcSEcCtD
Mifepristone—Headache—Hydrocortisone—systemic lupus erythematosus	8.1e-05	0.000946	CcSEcCtD
Mifepristone—Dizziness—Triamcinolone—systemic lupus erythematosus	8.05e-05	0.00094	CcSEcCtD
Mifepristone—Dizziness—Methylprednisolone—systemic lupus erythematosus	8.03e-05	0.000938	CcSEcCtD
Mifepristone—Infection—Methotrexate—systemic lupus erythematosus	7.99e-05	0.000933	CcSEcCtD
Mifepristone—Feeling abnormal—Prednisone—systemic lupus erythematosus	7.93e-05	0.000926	CcSEcCtD
Mifepristone—Asthenia—Dexamethasone—systemic lupus erythematosus	7.93e-05	0.000926	CcSEcCtD
Mifepristone—Asthenia—Betamethasone—systemic lupus erythematosus	7.93e-05	0.000926	CcSEcCtD
Mifepristone—Nervous system disorder—Methotrexate—systemic lupus erythematosus	7.88e-05	0.000921	CcSEcCtD
Mifepristone—Gastrointestinal pain—Prednisone—systemic lupus erythematosus	7.87e-05	0.000919	CcSEcCtD
Mifepristone—Nausea—Prednisolone—systemic lupus erythematosus	7.86e-05	0.000919	CcSEcCtD
Mifepristone—Pruritus—Dexamethasone—systemic lupus erythematosus	7.82e-05	0.000913	CcSEcCtD
Mifepristone—Pruritus—Betamethasone—systemic lupus erythematosus	7.82e-05	0.000913	CcSEcCtD
Mifepristone—Skin disorder—Methotrexate—systemic lupus erythematosus	7.81e-05	0.000912	CcSEcCtD
Mifepristone—Vomiting—Triamcinolone—systemic lupus erythematosus	7.74e-05	0.000904	CcSEcCtD
Mifepristone—Vomiting—Methylprednisolone—systemic lupus erythematosus	7.72e-05	0.000902	CcSEcCtD
Mifepristone—Nausea—Hydrocortisone—systemic lupus erythematosus	7.68e-05	0.000897	CcSEcCtD
Mifepristone—Rash—Triamcinolone—systemic lupus erythematosus	7.68e-05	0.000897	CcSEcCtD
Mifepristone—Dermatitis—Triamcinolone—systemic lupus erythematosus	7.67e-05	0.000896	CcSEcCtD
Mifepristone—Anorexia—Methotrexate—systemic lupus erythematosus	7.66e-05	0.000895	CcSEcCtD
Mifepristone—Rash—Methylprednisolone—systemic lupus erythematosus	7.66e-05	0.000895	CcSEcCtD
Mifepristone—Dermatitis—Methylprednisolone—systemic lupus erythematosus	7.65e-05	0.000894	CcSEcCtD
Mifepristone—Urticaria—Prednisone—systemic lupus erythematosus	7.64e-05	0.000893	CcSEcCtD
Mifepristone—Headache—Triamcinolone—systemic lupus erythematosus	7.63e-05	0.000891	CcSEcCtD
Mifepristone—Headache—Methylprednisolone—systemic lupus erythematosus	7.61e-05	0.000889	CcSEcCtD
Mifepristone—Body temperature increased—Prednisone—systemic lupus erythematosus	7.61e-05	0.000888	CcSEcCtD
Mifepristone—Abdominal pain—Prednisone—systemic lupus erythematosus	7.61e-05	0.000888	CcSEcCtD
Mifepristone—Diarrhoea—Betamethasone—systemic lupus erythematosus	7.56e-05	0.000883	CcSEcCtD
Mifepristone—Diarrhoea—Dexamethasone—systemic lupus erythematosus	7.56e-05	0.000883	CcSEcCtD
Mifepristone—Hypotension—Methotrexate—systemic lupus erythematosus	7.51e-05	0.000878	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Methotrexate—systemic lupus erythematosus	7.33e-05	0.000856	CcSEcCtD
Mifepristone—Dizziness—Betamethasone—systemic lupus erythematosus	7.31e-05	0.000853	CcSEcCtD
Mifepristone—Dizziness—Dexamethasone—systemic lupus erythematosus	7.31e-05	0.000853	CcSEcCtD
Mifepristone—Insomnia—Methotrexate—systemic lupus erythematosus	7.27e-05	0.000849	CcSEcCtD
Mifepristone—Nausea—Triamcinolone—systemic lupus erythematosus	7.23e-05	0.000845	CcSEcCtD
Mifepristone—Nausea—Methylprednisolone—systemic lupus erythematosus	7.22e-05	0.000843	CcSEcCtD
Mifepristone—Dyspnoea—Methotrexate—systemic lupus erythematosus	7.17e-05	0.000837	CcSEcCtD
Mifepristone—Somnolence—Methotrexate—systemic lupus erythematosus	7.15e-05	0.000835	CcSEcCtD
Mifepristone—Hypersensitivity—Prednisone—systemic lupus erythematosus	7.09e-05	0.000828	CcSEcCtD
Mifepristone—Vomiting—Betamethasone—systemic lupus erythematosus	7.02e-05	0.00082	CcSEcCtD
Mifepristone—Vomiting—Dexamethasone—systemic lupus erythematosus	7.02e-05	0.00082	CcSEcCtD
Mifepristone—Decreased appetite—Methotrexate—systemic lupus erythematosus	6.99e-05	0.000816	CcSEcCtD
Mifepristone—Rash—Dexamethasone—systemic lupus erythematosus	6.97e-05	0.000814	CcSEcCtD
Mifepristone—Rash—Betamethasone—systemic lupus erythematosus	6.97e-05	0.000814	CcSEcCtD
Mifepristone—Dermatitis—Dexamethasone—systemic lupus erythematosus	6.96e-05	0.000813	CcSEcCtD
Mifepristone—Dermatitis—Betamethasone—systemic lupus erythematosus	6.96e-05	0.000813	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	6.94e-05	0.000811	CcSEcCtD
Mifepristone—Fatigue—Methotrexate—systemic lupus erythematosus	6.93e-05	0.00081	CcSEcCtD
Mifepristone—Headache—Dexamethasone—systemic lupus erythematosus	6.92e-05	0.000808	CcSEcCtD
Mifepristone—Headache—Betamethasone—systemic lupus erythematosus	6.92e-05	0.000808	CcSEcCtD
Mifepristone—Asthenia—Prednisone—systemic lupus erythematosus	6.9e-05	0.000806	CcSEcCtD
Mifepristone—Pain—Methotrexate—systemic lupus erythematosus	6.88e-05	0.000803	CcSEcCtD
Mifepristone—Pruritus—Prednisone—systemic lupus erythematosus	6.81e-05	0.000795	CcSEcCtD
Mifepristone—Feeling abnormal—Methotrexate—systemic lupus erythematosus	6.63e-05	0.000774	CcSEcCtD
Mifepristone—Diarrhoea—Prednisone—systemic lupus erythematosus	6.58e-05	0.000769	CcSEcCtD
Mifepristone—Gastrointestinal pain—Methotrexate—systemic lupus erythematosus	6.57e-05	0.000768	CcSEcCtD
Mifepristone—Nausea—Dexamethasone—systemic lupus erythematosus	6.56e-05	0.000766	CcSEcCtD
Mifepristone—Nausea—Betamethasone—systemic lupus erythematosus	6.56e-05	0.000766	CcSEcCtD
Mifepristone—Urticaria—Methotrexate—systemic lupus erythematosus	6.39e-05	0.000746	CcSEcCtD
Mifepristone—Dizziness—Prednisone—systemic lupus erythematosus	6.36e-05	0.000743	CcSEcCtD
Mifepristone—Abdominal pain—Methotrexate—systemic lupus erythematosus	6.36e-05	0.000742	CcSEcCtD
Mifepristone—Body temperature increased—Methotrexate—systemic lupus erythematosus	6.36e-05	0.000742	CcSEcCtD
Mifepristone—Vomiting—Prednisone—systemic lupus erythematosus	6.12e-05	0.000714	CcSEcCtD
Mifepristone—Rash—Prednisone—systemic lupus erythematosus	6.07e-05	0.000709	CcSEcCtD
Mifepristone—Dermatitis—Prednisone—systemic lupus erythematosus	6.06e-05	0.000708	CcSEcCtD
Mifepristone—Headache—Prednisone—systemic lupus erythematosus	6.03e-05	0.000704	CcSEcCtD
Mifepristone—Hypersensitivity—Methotrexate—systemic lupus erythematosus	5.92e-05	0.000692	CcSEcCtD
Mifepristone—Asthenia—Methotrexate—systemic lupus erythematosus	5.77e-05	0.000674	CcSEcCtD
Mifepristone—Nausea—Prednisone—systemic lupus erythematosus	5.71e-05	0.000667	CcSEcCtD
Mifepristone—Pruritus—Methotrexate—systemic lupus erythematosus	5.69e-05	0.000664	CcSEcCtD
Mifepristone—Diarrhoea—Methotrexate—systemic lupus erythematosus	5.5e-05	0.000643	CcSEcCtD
Mifepristone—Dizziness—Methotrexate—systemic lupus erythematosus	5.32e-05	0.000621	CcSEcCtD
Mifepristone—Vomiting—Methotrexate—systemic lupus erythematosus	5.11e-05	0.000597	CcSEcCtD
Mifepristone—Rash—Methotrexate—systemic lupus erythematosus	5.07e-05	0.000592	CcSEcCtD
Mifepristone—Dermatitis—Methotrexate—systemic lupus erythematosus	5.06e-05	0.000592	CcSEcCtD
Mifepristone—NR3C1—Adipogenesis—RXRA—systemic lupus erythematosus	5.06e-05	0.00295	CbGpPWpGaD
Mifepristone—NR3C1—AP-1 transcription factor network—CCL2—systemic lupus erythematosus	5.06e-05	0.00295	CbGpPWpGaD
Mifepristone—Headache—Methotrexate—systemic lupus erythematosus	5.04e-05	0.000588	CcSEcCtD
Mifepristone—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—systemic lupus erythematosus	5.02e-05	0.00292	CbGpPWpGaD
Mifepristone—AR—Integrated Breast Cancer Pathway—JAK1—systemic lupus erythematosus	4.97e-05	0.0029	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—RXRA—systemic lupus erythematosus	4.9e-05	0.00285	CbGpPWpGaD
Mifepristone—ABCB1—Allograft Rejection—IL12B—systemic lupus erythematosus	4.88e-05	0.00284	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—MTA2—systemic lupus erythematosus	4.78e-05	0.00278	CbGpPWpGaD
Mifepristone—Nausea—Methotrexate—systemic lupus erythematosus	4.78e-05	0.000558	CcSEcCtD
Mifepristone—CYP2D6—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	4.75e-05	0.00277	CbGpPWpGaD
Mifepristone—ABCB1—Allograft Rejection—CXCL12—systemic lupus erythematosus	4.71e-05	0.00274	CbGpPWpGaD
Mifepristone—AR—SIDS Susceptibility Pathways—NR3C1—systemic lupus erythematosus	4.7e-05	0.00274	CbGpPWpGaD
Mifepristone—ABCB1—Allograft Rejection—CD40—systemic lupus erythematosus	4.65e-05	0.00271	CbGpPWpGaD
Mifepristone—ABCB1—Allograft Rejection—CTLA4—systemic lupus erythematosus	4.59e-05	0.00267	CbGpPWpGaD
Mifepristone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—systemic lupus erythematosus	4.43e-05	0.00258	CbGpPWpGaD
Mifepristone—NR3C1—AP-1 transcription factor network—IFNG—systemic lupus erythematosus	4.3e-05	0.0025	CbGpPWpGaD
Mifepristone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—systemic lupus erythematosus	4.28e-05	0.0025	CbGpPWpGaD
Mifepristone—NR3C1—Regulation of Androgen receptor activity—EP300—systemic lupus erythematosus	4.28e-05	0.0025	CbGpPWpGaD
Mifepristone—PGR—Signaling by ERBB4—TYK2—systemic lupus erythematosus	4.27e-05	0.00249	CbGpPWpGaD
Mifepristone—AR—Regulation of nuclear SMAD2/3 signaling—CDKN1A—systemic lupus erythematosus	4.23e-05	0.00246	CbGpPWpGaD
Mifepristone—NR3C1—Circadian Clock—EP300—systemic lupus erythematosus	4.16e-05	0.00242	CbGpPWpGaD
Mifepristone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—EP300—systemic lupus erythematosus	4.06e-05	0.00237	CbGpPWpGaD
Mifepristone—ABCB1—Allograft Rejection—HLA-DQA1—systemic lupus erythematosus	4.04e-05	0.00235	CbGpPWpGaD
Mifepristone—AR—Gene Expression—SNRPD1—systemic lupus erythematosus	4.03e-05	0.00234	CbGpPWpGaD
Mifepristone—AR—Regulation of nuclear SMAD2/3 signaling—EP300—systemic lupus erythematosus	4.02e-05	0.00234	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—FASLG—systemic lupus erythematosus	4.01e-05	0.00234	CbGpPWpGaD
Mifepristone—NR3C1—Adipogenesis—FAS—systemic lupus erythematosus	3.99e-05	0.00233	CbGpPWpGaD
Mifepristone—CYP3A7—Biological oxidations—RXRA—systemic lupus erythematosus	3.98e-05	0.00232	CbGpPWpGaD
Mifepristone—AR—Androgen receptor signaling pathway—CDKN1A—systemic lupus erythematosus	3.92e-05	0.00228	CbGpPWpGaD
Mifepristone—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—systemic lupus erythematosus	3.91e-05	0.00228	CbGpPWpGaD
Mifepristone—NR3C1—AP-1 transcription factor network—CDKN1B—systemic lupus erythematosus	3.9e-05	0.00227	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—FAS—systemic lupus erythematosus	3.87e-05	0.00225	CbGpPWpGaD
Mifepristone—CYP2D6—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	3.85e-05	0.00224	CbGpPWpGaD
Mifepristone—NR3C1—SIDS Susceptibility Pathways—IL10—systemic lupus erythematosus	3.85e-05	0.00224	CbGpPWpGaD
Mifepristone—NR3C1—AP-1 transcription factor network—IL2—systemic lupus erythematosus	3.82e-05	0.00223	CbGpPWpGaD
Mifepristone—NR3C1—Glucocorticoid receptor regulatory network—IFNG—systemic lupus erythematosus	3.79e-05	0.00221	CbGpPWpGaD
Mifepristone—ABCB1—Allograft Rejection—HLA-DQB1—systemic lupus erythematosus	3.78e-05	0.0022	CbGpPWpGaD
Mifepristone—AR—Androgen receptor signaling pathway—EP300—systemic lupus erythematosus	3.73e-05	0.00217	CbGpPWpGaD
Mifepristone—CYP2D6—Biological oxidations—NAT2—systemic lupus erythematosus	3.65e-05	0.00213	CbGpPWpGaD
Mifepristone—PGR—Generic Transcription Pathway—JUNB—systemic lupus erythematosus	3.65e-05	0.00212	CbGpPWpGaD
Mifepristone—AR—Gene Expression—MTA2—systemic lupus erythematosus	3.64e-05	0.00212	CbGpPWpGaD
Mifepristone—PGR—Signaling by ERBB4—CDKN1B—systemic lupus erythematosus	3.63e-05	0.00212	CbGpPWpGaD
Mifepristone—NR3C1—AP-1 transcription factor network—MMP9—systemic lupus erythematosus	3.62e-05	0.00211	CbGpPWpGaD
Mifepristone—CYP2D6—Metapathway biotransformation—NAT2—systemic lupus erythematosus	3.6e-05	0.0021	CbGpPWpGaD
Mifepristone—ABCB1—Allograft Rejection—IL10—systemic lupus erythematosus	3.57e-05	0.00208	CbGpPWpGaD
Mifepristone—ABCB1—Allograft Rejection—CD40LG—systemic lupus erythematosus	3.57e-05	0.00208	CbGpPWpGaD
Mifepristone—ABCB1—Allograft Rejection—IL4—systemic lupus erythematosus	3.47e-05	0.00202	CbGpPWpGaD
Mifepristone—NR3C1—AP-1 transcription factor network—EP300—systemic lupus erythematosus	3.43e-05	0.002	CbGpPWpGaD
Mifepristone—NR3C1—Glucocorticoid receptor regulatory network—IL2—systemic lupus erythematosus	3.37e-05	0.00196	CbGpPWpGaD
Mifepristone—PGR—Signaling by ERBB4—CDKN1A—systemic lupus erythematosus	3.35e-05	0.00195	CbGpPWpGaD
Mifepristone—ABCB1—Allograft Rejection—FASLG—systemic lupus erythematosus	3.32e-05	0.00193	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—TNFSF13—systemic lupus erythematosus	3.23e-05	0.00188	CbGpPWpGaD
Mifepristone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—systemic lupus erythematosus	3.21e-05	0.00187	CbGpPWpGaD
Mifepristone—ABCB1—Allograft Rejection—FAS—systemic lupus erythematosus	3.2e-05	0.00186	CbGpPWpGaD
Mifepristone—PGR—Generic Transcription Pathway—RXRA—systemic lupus erythematosus	3.2e-05	0.00186	CbGpPWpGaD
Mifepristone—NR3C1—Adipogenesis—PPARG—systemic lupus erythematosus	3.19e-05	0.00186	CbGpPWpGaD
Mifepristone—ABCB1—Allograft Rejection—IL2RA—systemic lupus erythematosus	3.18e-05	0.00185	CbGpPWpGaD
Mifepristone—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—systemic lupus erythematosus	3.17e-05	0.00185	CbGpPWpGaD
Mifepristone—ABCB1—Allograft Rejection—C3—systemic lupus erythematosus	3.15e-05	0.00184	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—SNRPB—systemic lupus erythematosus	3.13e-05	0.00182	CbGpPWpGaD
Mifepristone—ABCB1—Transmembrane transport of small molecules—SLC15A4—systemic lupus erythematosus	3.12e-05	0.00182	CbGpPWpGaD
Mifepristone—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	3.11e-05	0.00181	CbGpPWpGaD
Mifepristone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—systemic lupus erythematosus	3.09e-05	0.0018	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—SNRPD1—systemic lupus erythematosus	3.05e-05	0.00178	CbGpPWpGaD
Mifepristone—NR3C1—Regulation of nuclear SMAD2/3 signaling—EP300—systemic lupus erythematosus	3.05e-05	0.00178	CbGpPWpGaD
Mifepristone—NR3C1—Endoderm Differentiation—TGFB1—systemic lupus erythematosus	3.05e-05	0.00178	CbGpPWpGaD
Mifepristone—NR3C1—Glucocorticoid receptor regulatory network—EP300—systemic lupus erythematosus	3.02e-05	0.00176	CbGpPWpGaD
Mifepristone—NR3C1—AP-1 transcription factor network—TGFB1—systemic lupus erythematosus	2.98e-05	0.00174	CbGpPWpGaD
Mifepristone—PGR—Generic Transcription Pathway—VDR—systemic lupus erythematosus	2.89e-05	0.00169	CbGpPWpGaD
Mifepristone—CYP3A5—Biological oxidations—RXRA—systemic lupus erythematosus	2.88e-05	0.00168	CbGpPWpGaD
Mifepristone—ABCB1—Allograft Rejection—HLA-DRB1—systemic lupus erythematosus	2.87e-05	0.00167	CbGpPWpGaD
Mifepristone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—systemic lupus erythematosus	2.79e-05	0.00163	CbGpPWpGaD
Mifepristone—AR—Generic Transcription Pathway—JUNB—systemic lupus erythematosus	2.78e-05	0.00162	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—MTA2—systemic lupus erythematosus	2.76e-05	0.00161	CbGpPWpGaD
Mifepristone—ABCB1—Allograft Rejection—CD80—systemic lupus erythematosus	2.65e-05	0.00155	CbGpPWpGaD
Mifepristone—PGR—Generic Transcription Pathway—NR3C1—systemic lupus erythematosus	2.6e-05	0.00152	CbGpPWpGaD
Mifepristone—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	2.52e-05	0.00147	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—HIST2H2AC—systemic lupus erythematosus	2.51e-05	0.00146	CbGpPWpGaD
Mifepristone—AR—Gene Expression—TNFSF13—systemic lupus erythematosus	2.46e-05	0.00143	CbGpPWpGaD
Mifepristone—AR—Integrated Breast Cancer Pathway—EP300—systemic lupus erythematosus	2.44e-05	0.00142	CbGpPWpGaD
Mifepristone—AR—Generic Transcription Pathway—RXRA—systemic lupus erythematosus	2.43e-05	0.00142	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—PTGS2—systemic lupus erythematosus	2.43e-05	0.00142	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—GADD45A—systemic lupus erythematosus	2.42e-05	0.00141	CbGpPWpGaD
Mifepristone—CYP3A4—Biological oxidations—NAT2—systemic lupus erythematosus	2.39e-05	0.00139	CbGpPWpGaD
Mifepristone—AR—Gene Expression—SNRPB—systemic lupus erythematosus	2.38e-05	0.00139	CbGpPWpGaD
Mifepristone—AR—SIDS Susceptibility Pathways—EP300—systemic lupus erythematosus	2.38e-05	0.00139	CbGpPWpGaD
Mifepristone—CYP3A4—Metapathway biotransformation—NAT2—systemic lupus erythematosus	2.35e-05	0.00137	CbGpPWpGaD
Mifepristone—AR—Integrated Breast Cancer Pathway—VEGFA—systemic lupus erythematosus	2.31e-05	0.00135	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—CDKN1B—systemic lupus erythematosus	2.31e-05	0.00134	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—JUNB—systemic lupus erythematosus	2.28e-05	0.00133	CbGpPWpGaD
Mifepristone—AR—SIDS Susceptibility Pathways—VEGFA—systemic lupus erythematosus	2.25e-05	0.00131	CbGpPWpGaD
Mifepristone—NR3C1—AP-1 transcription factor network—IL6—systemic lupus erythematosus	2.25e-05	0.00131	CbGpPWpGaD
Mifepristone—AR—Generic Transcription Pathway—VDR—systemic lupus erythematosus	2.2e-05	0.00128	CbGpPWpGaD
Mifepristone—NR3C1—Adipogenesis—CDKN1A—systemic lupus erythematosus	2.2e-05	0.00128	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—CDKN1A—systemic lupus erythematosus	2.13e-05	0.00124	CbGpPWpGaD
Mifepristone—NR3C1—Generic Transcription Pathway—JUNB—systemic lupus erythematosus	2.11e-05	0.00123	CbGpPWpGaD
Mifepristone—ABCB1—Allograft Rejection—IFNG—systemic lupus erythematosus	2.1e-05	0.00122	CbGpPWpGaD
Mifepristone—PGR—Signaling by ERBB4—IL6—systemic lupus erythematosus	2.09e-05	0.00122	CbGpPWpGaD
Mifepristone—ABCC1—Disease—XRCC6—systemic lupus erythematosus	2.06e-05	0.0012	CbGpPWpGaD
Mifepristone—CYP2D6—Biological oxidations—RXRA—systemic lupus erythematosus	2.05e-05	0.00119	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—EP300—systemic lupus erythematosus	2.02e-05	0.00118	CbGpPWpGaD
Mifepristone—PGR—Generic Transcription Pathway—PPARG—systemic lupus erythematosus	2.02e-05	0.00118	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—RXRA—systemic lupus erythematosus	2e-05	0.00116	CbGpPWpGaD
Mifepristone—AR—Generic Transcription Pathway—NR3C1—systemic lupus erythematosus	1.98e-05	0.00116	CbGpPWpGaD
Mifepristone—NR3C1—Glucocorticoid receptor regulatory network—IL6—systemic lupus erythematosus	1.98e-05	0.00115	CbGpPWpGaD
Mifepristone—AR—SIDS Susceptibility Pathways—TNF—systemic lupus erythematosus	1.93e-05	0.00113	CbGpPWpGaD
Mifepristone—ABCB1—HIF-1-alpha transcription factor network—EP300—systemic lupus erythematosus	1.93e-05	0.00112	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—VEGFA—systemic lupus erythematosus	1.92e-05	0.00112	CbGpPWpGaD
Mifepristone—AR—Gene Expression—HIST2H2AC—systemic lupus erythematosus	1.91e-05	0.00111	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—TNFSF13—systemic lupus erythematosus	1.87e-05	0.00109	CbGpPWpGaD
Mifepristone—ABCB1—Allograft Rejection—IL2—systemic lupus erythematosus	1.86e-05	0.00109	CbGpPWpGaD
Mifepristone—NR3C1—Generic Transcription Pathway—RXRA—systemic lupus erythematosus	1.85e-05	0.00108	CbGpPWpGaD
Mifepristone—ABCB1—HIF-1-alpha transcription factor network—VEGFA—systemic lupus erythematosus	1.83e-05	0.00107	CbGpPWpGaD
Mifepristone—NR3C1—Adipogenesis—TGFB1—systemic lupus erythematosus	1.82e-05	0.00106	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—SNRPB—systemic lupus erythematosus	1.81e-05	0.00105	CbGpPWpGaD
Mifepristone—NR3C1—SIDS Susceptibility Pathways—EP300—systemic lupus erythematosus	1.81e-05	0.00105	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—TLR9—systemic lupus erythematosus	1.78e-05	0.00104	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	1.76e-05	0.00103	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—JUNB—systemic lupus erythematosus	1.76e-05	0.00102	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	1.75e-05	0.00102	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—P2RY12—systemic lupus erythematosus	1.73e-05	0.00101	CbGpPWpGaD
Mifepristone—NR3C1—SIDS Susceptibility Pathways—VEGFA—systemic lupus erythematosus	1.71e-05	0.000996	CbGpPWpGaD
Mifepristone—NR3C1—Adipogenesis—TNF—systemic lupus erythematosus	1.7e-05	0.000988	CbGpPWpGaD
Mifepristone—NR3C1—Generic Transcription Pathway—VDR—systemic lupus erythematosus	1.67e-05	0.000974	CbGpPWpGaD
Mifepristone—ABCC1—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	1.67e-05	0.000971	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	1.64e-05	0.000957	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—systemic lupus erythematosus	1.64e-05	0.000953	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	1.63e-05	0.000951	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CSK—systemic lupus erythematosus	1.59e-05	0.000926	CbGpPWpGaD
Mifepristone—ABCB1—Allograft Rejection—VEGFA—systemic lupus erythematosus	1.58e-05	0.000923	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—systemic lupus erythematosus	1.58e-05	0.000919	CbGpPWpGaD
Mifepristone—AR—SIDS Susceptibility Pathways—IL6—systemic lupus erythematosus	1.56e-05	0.000908	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—RXRA—systemic lupus erythematosus	1.54e-05	0.000896	CbGpPWpGaD
Mifepristone—AR—Generic Transcription Pathway—PPARG—systemic lupus erythematosus	1.54e-05	0.000895	CbGpPWpGaD
Mifepristone—ABCC1—Disease—HIST2H2AC—systemic lupus erythematosus	1.52e-05	0.000886	CbGpPWpGaD
Mifepristone—ABCC1—Disease—CSK—systemic lupus erythematosus	1.48e-05	0.000864	CbGpPWpGaD
Mifepristone—NR3C1—SIDS Susceptibility Pathways—TNF—systemic lupus erythematosus	1.47e-05	0.000854	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—NCF2—systemic lupus erythematosus	1.45e-05	0.000847	CbGpPWpGaD
Mifepristone—ABCB1—Allograft Rejection—TGFB1—systemic lupus erythematosus	1.45e-05	0.000847	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—HIST2H2AC—systemic lupus erythematosus	1.45e-05	0.000845	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—LYN—systemic lupus erythematosus	1.44e-05	0.000842	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—SH2B3—systemic lupus erythematosus	1.42e-05	0.000826	CbGpPWpGaD
Mifepristone—ABCC1—Disease—CD247—systemic lupus erythematosus	1.39e-05	0.000812	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—VDR—systemic lupus erythematosus	1.39e-05	0.000812	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—NAT2—systemic lupus erythematosus	1.39e-05	0.000811	CbGpPWpGaD
Mifepristone—NR3C1—Adipogenesis—IL6—systemic lupus erythematosus	1.37e-05	0.000797	CbGpPWpGaD
Mifepristone—ABCB1—Allograft Rejection—TNF—systemic lupus erythematosus	1.36e-05	0.000791	CbGpPWpGaD
Mifepristone—ABCC1—Disease—NCF2—systemic lupus erythematosus	1.36e-05	0.00079	CbGpPWpGaD
Mifepristone—CYP3A4—Biological oxidations—RXRA—systemic lupus erythematosus	1.34e-05	0.00078	CbGpPWpGaD
Mifepristone—AR—Gene Expression—JUNB—systemic lupus erythematosus	1.34e-05	0.000779	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—NR3C1—systemic lupus erythematosus	1.25e-05	0.000731	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—NAT2—systemic lupus erythematosus	1.21e-05	0.000708	CbGpPWpGaD
Mifepristone—NR3C1—SIDS Susceptibility Pathways—IL6—systemic lupus erythematosus	1.18e-05	0.000689	CbGpPWpGaD
Mifepristone—AR—Gene Expression—RXRA—systemic lupus erythematosus	1.17e-05	0.000683	CbGpPWpGaD
Mifepristone—NR3C1—Generic Transcription Pathway—PPARG—systemic lupus erythematosus	1.17e-05	0.000679	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CXCL12—systemic lupus erythematosus	1.16e-05	0.000677	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—JUNB—systemic lupus erythematosus	1.14e-05	0.000665	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	1.11e-05	0.000645	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—RASGRP1—systemic lupus erythematosus	1.08e-05	0.000632	CbGpPWpGaD
Mifepristone—ABCC1—Disease—JUNB—systemic lupus erythematosus	1.06e-05	0.00062	CbGpPWpGaD
Mifepristone—AR—Gene Expression—VDR—systemic lupus erythematosus	1.06e-05	0.000618	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—PRL—systemic lupus erythematosus	1.05e-05	0.000613	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—JUNB—systemic lupus erythematosus	1.01e-05	0.000591	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	9.95e-06	0.00058	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—systemic lupus erythematosus	9.92e-06	0.000578	CbGpPWpGaD
Mifepristone—ABCC1—Disease—PRL—systemic lupus erythematosus	9.8e-06	0.000571	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—PPARG—systemic lupus erythematosus	9.71e-06	0.000566	CbGpPWpGaD
Mifepristone—AR—Gene Expression—NR3C1—systemic lupus erythematosus	9.55e-06	0.000557	CbGpPWpGaD
Mifepristone—ABCC1—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	9.46e-06	0.000551	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—systemic lupus erythematosus	9.4e-06	0.000547	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—RXRA—systemic lupus erythematosus	8.89e-06	0.000518	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—NAT2—systemic lupus erythematosus	8.78e-06	0.000512	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	8.71e-06	0.000507	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—systemic lupus erythematosus	8.67e-06	0.000505	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—JAK1—systemic lupus erythematosus	8.41e-06	0.00049	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—systemic lupus erythematosus	8.25e-06	0.000481	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—VDR—systemic lupus erythematosus	8.05e-06	0.000469	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CCR5—systemic lupus erythematosus	7.97e-06	0.000464	CbGpPWpGaD
Mifepristone—ABCB1—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	7.93e-06	0.000462	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—IL2RA—systemic lupus erythematosus	7.85e-06	0.000458	CbGpPWpGaD
Mifepristone—ABCC1—Disease—JAK1—systemic lupus erythematosus	7.84e-06	0.000457	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—systemic lupus erythematosus	7.81e-06	0.000455	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—RXRA—systemic lupus erythematosus	7.81e-06	0.000455	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—C3—systemic lupus erythematosus	7.79e-06	0.000454	CbGpPWpGaD
Mifepristone—ABCC1—Disease—CCR5—systemic lupus erythematosus	7.43e-06	0.000433	CbGpPWpGaD
Mifepristone—AR—Gene Expression—PPARG—systemic lupus erythematosus	7.4e-06	0.000431	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	7.24e-06	0.000422	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	7.17e-06	0.000418	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—F2—systemic lupus erythematosus	6.84e-06	0.000398	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—RXRA—systemic lupus erythematosus	6.81e-06	0.000397	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	6.7e-06	0.00039	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—NAT2—systemic lupus erythematosus	6.63e-06	0.000386	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CD80—systemic lupus erythematosus	6.56e-06	0.000382	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—NAT2—systemic lupus erythematosus	6.24e-06	0.000364	CbGpPWpGaD
Mifepristone—ABCC1—Disease—CD80—systemic lupus erythematosus	6.11e-06	0.000356	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CCL2—systemic lupus erythematosus	6.09e-06	0.000355	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—PPARG—systemic lupus erythematosus	5.61e-06	0.000327	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—TYK2—systemic lupus erythematosus	5.53e-06	0.000322	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—NOS3—systemic lupus erythematosus	5.43e-06	0.000316	CbGpPWpGaD
Mifepristone—ABCC1—Disease—TYK2—systemic lupus erythematosus	5.16e-06	0.0003	CbGpPWpGaD
Mifepristone—ABCC1—Disease—NOS3—systemic lupus erythematosus	5.06e-06	0.000295	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—PPARG—systemic lupus erythematosus	4.93e-06	0.000287	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—RXRA—systemic lupus erythematosus	4.92e-06	0.000287	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CDKN1B—systemic lupus erythematosus	4.71e-06	0.000274	CbGpPWpGaD
Mifepristone—ABCC1—Disease—CD4—systemic lupus erythematosus	4.66e-06	0.000272	CbGpPWpGaD
Mifepristone—ABCC1—Disease—PTGS2—systemic lupus erythematosus	4.63e-06	0.00027	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—IL2—systemic lupus erythematosus	4.6e-06	0.000268	CbGpPWpGaD
Mifepristone—ABCB1—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	4.5e-06	0.000262	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—ALB—systemic lupus erythematosus	4.43e-06	0.000258	CbGpPWpGaD
Mifepristone—ABCC1—Disease—CDKN1B—systemic lupus erythematosus	4.39e-06	0.000256	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—MMP9—systemic lupus erythematosus	4.36e-06	0.000254	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CDKN1A—systemic lupus erythematosus	4.34e-06	0.000253	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—PPARG—systemic lupus erythematosus	4.3e-06	0.00025	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—NOS3—systemic lupus erythematosus	4.24e-06	0.000247	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—EP300—systemic lupus erythematosus	4.13e-06	0.000241	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—NAT2—systemic lupus erythematosus	4.08e-06	0.000238	CbGpPWpGaD
Mifepristone—ABCC1—Disease—CDKN1A—systemic lupus erythematosus	4.05e-06	0.000236	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—VEGFA—systemic lupus erythematosus	3.91e-06	0.000228	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—PTGS2—systemic lupus erythematosus	3.88e-06	0.000226	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—ALB—systemic lupus erythematosus	3.87e-06	0.000225	CbGpPWpGaD
Mifepristone—ABCC1—Disease—EP300—systemic lupus erythematosus	3.85e-06	0.000224	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—RXRA—systemic lupus erythematosus	3.71e-06	0.000216	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—NOS3—systemic lupus erythematosus	3.7e-06	0.000215	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—TGFB1—systemic lupus erythematosus	3.59e-06	0.000209	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—RXRA—systemic lupus erythematosus	3.5e-06	0.000204	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—PTGS2—systemic lupus erythematosus	3.38e-06	0.000197	CbGpPWpGaD
Mifepristone—ABCC1—Disease—TGFB1—systemic lupus erythematosus	3.35e-06	0.000195	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—EP300—systemic lupus erythematosus	3.23e-06	0.000188	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PPARG—systemic lupus erythematosus	3.11e-06	0.000181	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—EP300—systemic lupus erythematosus	2.81e-06	0.000164	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—ALB—systemic lupus erythematosus	2.79e-06	0.000163	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—IL6—systemic lupus erythematosus	2.71e-06	0.000158	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—NOS3—systemic lupus erythematosus	2.67e-06	0.000156	CbGpPWpGaD
Mifepristone—ABCC1—Disease—IL6—systemic lupus erythematosus	2.52e-06	0.000147	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PTGS2—systemic lupus erythematosus	2.44e-06	0.000142	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PPARG—systemic lupus erythematosus	2.35e-06	0.000137	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—RXRA—systemic lupus erythematosus	2.29e-06	0.000133	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PPARG—systemic lupus erythematosus	2.21e-06	0.000129	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—ALB—systemic lupus erythematosus	2.11e-06	0.000123	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—EP300—systemic lupus erythematosus	2.03e-06	0.000118	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—NOS3—systemic lupus erythematosus	2.02e-06	0.000118	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—ALB—systemic lupus erythematosus	1.99e-06	0.000116	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—NOS3—systemic lupus erythematosus	1.9e-06	0.000111	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PTGS2—systemic lupus erythematosus	1.84e-06	0.000107	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PTGS2—systemic lupus erythematosus	1.74e-06	0.000101	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—EP300—systemic lupus erythematosus	1.53e-06	8.94e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—EP300—systemic lupus erythematosus	1.45e-06	8.42e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PPARG—systemic lupus erythematosus	1.44e-06	8.42e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—ALB—systemic lupus erythematosus	1.3e-06	7.57e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—NOS3—systemic lupus erythematosus	1.24e-06	7.24e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PTGS2—systemic lupus erythematosus	1.14e-06	6.62e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—EP300—systemic lupus erythematosus	9.45e-07	5.51e-05	CbGpPWpGaD
